PMID- 34706819 OWN - NLM STAT- MEDLINE DCOM- 20220128 LR - 20220128 IS - 1879-1913 (Electronic) IS - 0002-9149 (Linking) VI - 162 DP - 2022 Jan 1 TI - Effects of Adding Respiratory Training to Osteopathic Manipulative Treatment on Exhaled Nitric Oxide Level and Cardiopulmonary Function in Patients With Pulmonary Arterial Hypertension. PG - 184-190 LID - S0002-9149(21)00946-2 [pii] LID - 10.1016/j.amjcard.2021.09.023 [doi] AB - Limited research exists regarding nonpharmacologic management of pulmonary arterial hypertension (PAH), except for exercise training. The objective of this study was to investigate the effects of osteopathic manipulative treatment (OMT) alone and combined with respiratory training on fractional exhaled nitric oxide (FeNO), and cardiopulmonary function in patients with PAH. This single-blind, prospective, randomized controlled study included 54 patients with PAH who were randomly allocated to OMT, combined intervention, and control groups. The OMT group (n = 16) and combined intervention group (n = 16) received OMT and yoga respiratory training plus OMT, respectively, twice a week for 8 weeks. The control group (n = 16) received no intervention. All patients undertook an educational lecture. FeNO level, pulmonary function, 6-minute walk distance (6MWD), maximal inspiratory and expiratory pressures, and handgrip strength were assessed at baseline and 8 weeks. Combined intervention and OMT groups significantly improved all outcome measures after 8 weeks of treatment (p <0.01), except mean forced expiratory flow between 25% and 75% of forced vital capacity, which did not change in the OMT group (p >0.05). The control group showed significant deteriorations in 6MWD, inspiratory and peripheral muscle strength, and pulmonary function except peak expiratory flow at 8 weeks (p <0.05). The combined intervention group revealed significantly greater improvements of FeNO, 6MWD, respiratory and peripheral muscle strength, and pulmonary function except mean forced expiratory flow between 25% and 75% of forced vital capacity compared with the OMT group (p <0.05). All outcomes significantly improved in both intervention groups versus the control group (p <0.05). Our study demonstrated that adding respiratory training to OMT provided further benefit to FeNO level and cardiopulmonary function compared with OMT alone and that the OMT might be a useful and safe intervention for patients who cannot attend cardiac rehabilitation programs. CI - Copyright (c) 2021 Elsevier Inc. All rights reserved. FAU - Naci, Baha AU - Naci B AD - Department of Cardiology, Institute of Cardiology, Istanbul University-Cerrahpasa, Istanbul, Turkey; Division of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Fenerbahce University, Istanbul, Turkey. FAU - Demir, Rengin AU - Demir R AD - Department of Cardiology, Institute of Cardiology, Istanbul University-Cerrahpasa, Istanbul, Turkey. Electronic address: rengindemir@yahoo.com. FAU - Onder, Omer O AU - Onder OO AD - Division of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Istanbul Health and Technology University, Istanbul, Turkey. FAU - Sinan, Umit Yasar AU - Sinan UY AD - Department of Cardiology, Institute of Cardiology, Istanbul University-Cerrahpasa, Istanbul, Turkey. FAU - Kucukoglu, Mehmet Serdar AU - Kucukoglu MS AD - Department of Cardiology, Institute of Cardiology, Istanbul University-Cerrahpasa, Istanbul, Turkey. LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20211024 PL - United States TA - Am J Cardiol JT - The American journal of cardiology JID - 0207277 SB - IM MH - Adult MH - *Breathing Exercises MH - Female MH - Fractional Exhaled Nitric Oxide Testing MH - Humans MH - Male MH - *Manipulation, Osteopathic MH - Middle Aged MH - Muscle Strength MH - Outcome Assessment, Health Care MH - Prospective Studies MH - Pulmonary Arterial Hypertension/complications/physiopathology/*rehabilitation MH - Recovery of Function MH - Respiratory Function Tests MH - Single-Blind Method MH - Walk Test MH - *Yoga COIS- Disclosures The authors have no conflicts of interest to declare. EDAT- 2021/10/29 06:00 MHDA- 2022/01/29 06:00 CRDT- 2021/10/28 05:36 PHST- 2021/06/24 00:00 [received] PHST- 2021/09/14 00:00 [revised] PHST- 2021/09/17 00:00 [accepted] PHST- 2021/10/29 06:00 [pubmed] PHST- 2022/01/29 06:00 [medline] PHST- 2021/10/28 05:36 [entrez] AID - S0002-9149(21)00946-2 [pii] AID - 10.1016/j.amjcard.2021.09.023 [doi] PST - ppublish SO - Am J Cardiol. 2022 Jan 1;162:184-190. doi: 10.1016/j.amjcard.2021.09.023. Epub 2021 Oct 24.